← Back to all protocols
13

Acute Childhood Asthma (Pediatric, 1–18y)Pediatric

1 · ED Quick Pathway

Child 1–18y with known/suspected asthma and wheeze presents in respiratory distress
↓
Exclude: first-episode wheeze <1y (consider bronchiolitis) · inspiratory stridor/upper-airway obstruction · other diagnoses (see Section 12)
↓
Rapid visual triage: work of breathing, ability to speak/feed, mental status, colour — if any critical sign present, treat as severe/impending failure immediately, do not wait for a formal score
↓
Score PRAM (Section 3) before treatment and attach continuous SpO₂ + vitals
↓
Start severity-appropriate bronchodilator therapy without delay (Sections 5–7)
↓
Reassess PRAM + clinical trajectory after every treatment phase (Section 4)

2 · Initial Assessment

  • History: known asthma diagnosis, usual severity/triggers, prior ICU admission or intubation (major risk factor), current reliever/preventer use, time and response to any treatment already given at home, allergies
  • Examination: work of breathing, accessory muscle use, air entry, wheeze character, SpO₂ on room air, respiratory rate, heart rate, mental status, ability to speak/feed in full sentences
  • Red flags on arrival: silent chest, cyanosis, exhaustion, altered mental status, inability to speak or feed — these mandate immediate severe/impending-failure management regardless of PRAM
  • Continuous SpO₂ and cardiorespiratory monitoring for moderate–severe presentations

3 · Asthma Severity Classification — PRAM Score

PRAM component0123
Suprasternal retractionAbsentPresent——
Scalene muscle contractionAbsentPresent——
Air entryNormalDecreased at basesWidespread decreaseMinimal/no air entry
WheezingNoneExpiratory onlyInspiratory + expiratoryAudible without stethoscope
SpO₂ on room air≥95%92–94%<92%—

3b · Severity Bands

  • Maximum PRAM = 12. Use the Pediatric Respiratory Assessment Measure for children 1–18 years. Score before treatment and again after each treatment phase
  • PRAM 0–4 — Mild asthma: minimal respiratory distress · normal or mildly decreased air entry · usually responds rapidly to inhaled salbutamol · no significant hypoxaemia
  • PRAM 5–8 — Moderate asthma: increased work of breathing · clear wheezing and/or reduced air entry · requires repeated bronchodilator therapy · may have mild hypoxaemia
  • PRAM 9–12 — Severe asthma / impending respiratory failure: marked respiratory distress or exhaustion · very poor/minimal air entry or silent chest · severe hypoxaemia · altered mental status, agitation, drowsiness or inability to speak/feed are major warning signs — treat as life-threatening asthma and involve PICU/airway expertise early

4 · Important Clinical Caveat — PRAM Has Limits

  • Do not use PRAM alone to determine severity.
  • A child with a silent chest may have little or no wheezing and therefore can receive a deceptively low wheeze score despite critical airflow obstruction
  • Escalate immediately if there is: exhaustion or deteriorating mental status · inability to speak/feed because of respiratory distress · cyanosis or persistent hypoxaemia · silent chest/minimal air entry · poor respiratory effort · rising CO₂ with clinical deterioration · bradycardia, hypotension or other signs of impending cardiovascular collapse · failure to respond to repeated inhaled salbutamol + ipratropium, systemic corticosteroid and IV magnesium
  • Clinical appearance and trajectory override the numerical PRAM score.

5 · Mild Asthma (PRAM 0–4) — Treatment

  • Salbutamol: 1–2 puffs (100 mcg/puff) via MDI + spacer, repeat up to 3 doses 20 minutes apart if needed
  • Corticosteroid: consider an oral dose if risk factors present (poor control, recent exacerbation, prior ICU admission) — see Section 10 for dosing
  • Observe for 1 hour post-salbutamol
  • Discharge if: PRAM ≤3, stable on room air, tolerating oral intake, reliable follow-up and return precautions understood (see Section 11)

6 · Moderate Asthma (PRAM 5–8) — Treatment

  • Salbutamol + ipratropium: combined, ×3 doses within 60 minutes via MDI + spacer or nebulizer (see Section 13 for weight-based dosing)
  • Corticosteroid: give after the first bronchodilator aerosol, oral unless vomiting — see Section 10 for dosing
  • Reassess PRAM, SpO₂ and work of breathing every 30–60 minutes
  • Admit if: PRAM score remains >3 at ≥4 hours post-steroid, persistent oxygen requirement, or repeated bronchodilator need beyond the initial protocol
  • Escalate to the severe pathway (Section 7) if there is no improvement, or deterioration, at any point

7 · Severe Asthma / Impending Respiratory Failure (PRAM 9–12)

  • Continuous nebulized salbutamol + ipratropium (see Section 13 for dosing)
  • Oxygen: titrate to keep SpO₂ ≥95% (impending failure: 100% O₂ 8–10 L/min via nebulizer mask)
  • IV access: establish immediately (IO if no IV access obtainable promptly in impending failure); start IV fluids if indicated
  • Corticosteroid: IV/IM if vomiting or impending failure, oral otherwise — do not delay for IV access if oral/IM is quicker (see Section 10)
  • IV magnesium sulfate: 40–50 mg/kg IV over 20 minutes (max 2 g); may repeat once if inadequate response
  • Impending failure additions: two IV lines (or IO) · IV/IO/IM steroids · consider IM epinephrine 0.01 mg/kg of 1:1000 (max 0.5 mg) · consider starting an IV salbutamol infusion (loading 15 mcg/kg over 10 min, then 1–5 mcg/kg/min)
  • Clinically assess for pneumothorax/barotrauma; obtain CXR if time and stability allow
  • Get the most experienced help available and involve PICU/critical-care transport early
  • Do NOT intubate routinely — positive-pressure ventilation in severe bronchospasm carries high risk of barotrauma and haemodynamic collapse; reserve for true respiratory arrest or exhaustion unresponsive to maximal therapy
  • If intubation is unavoidable: most experienced airway operator; RSI with atropine, ketamine and succinylcholine; cuffed ETT; low tidal volume ventilation (4 mL/kg), permissive hypercapnia, long expiratory time; re-check for barotrauma/pneumothorax after intubation

8 · Adjunct Therapies for Refractory Severe Asthma

  • These are considered for severe asthma not responding to first-line bronchodilators, steroids and magnesium — involve senior/critical-care input before starting
  • IV salbutamol infusion: as above, titrated to effect with continuous cardiac monitoring (watch for tachycardia, lactic acidosis, hypokalaemia)
  • Aminophylline: may be considered as a further adjunct in refractory cases under specialist guidance — narrow therapeutic index, requires levels and cardiac monitoring
  • Heliox: may be considered as a temporising measure in severe upper-airway-component obstruction while arranging escalation — limited evidence, not a substitute for definitive therapy
  • Non-invasive ventilation: may be trialled in a cooperative, not-yet-exhausted patient under close monitoring, as a bridge while other therapies take effect

9 · Response to Treatment

  • After initial bronchodilator therapy, repeat: PRAM score · SpO₂ · respiratory rate · heart rate · work of breathing · air entry/wheeze · mental status · ability to speak/feed
  • Document whether the child is: Improving → Stable → Failing treatment → Impending respiratory failure
  • Use the trend in PRAM and clinical condition, rather than a single score, to guide escalation, admission and discharge decisions

10 · Corticosteroid Dosing

  • Dexamethasone: 0.3–0.6 mg/kg PO/IV/IM (max 16 mg), single dose or as a short course per local practice
  • Prednisolone/prednisone: 1–2 mg/kg PO (max 40–60 mg) once daily for 3–5 days, no taper needed for short courses
  • Use IV or IM corticosteroid if the child is vomiting or cannot tolerate oral medication

11 · Discharge Planning

  • Reliever: inhaled salbutamol every 4 hours for 12 hours post-discharge, then as needed
  • Preventer: continue or start an inhaled corticosteroid per the child's usual asthma plan
  • Provide a written short-term management/action plan and clear return precautions
  • Arrange community physician follow-up within 3–7 days
  • Discourage routine antibiotic use — most exacerbations are not bacterial
  • Confirm inhaler/spacer technique before discharge

12 · Admission Criteria & Key Differentials

  • Consider admission if: PRAM score remains >3 at ≥4 hours post-steroid · persistent supplemental oxygen requirement · repeated bronchodilator need beyond the standard protocol · any severe/impending-failure presentation · significant comorbidity or social/access concerns affecting safe discharge
  • Always involve PICU/critical care for: any severe asthma requiring IV magnesium or escalation beyond standard therapy, impending respiratory failure, or intubation
  • Key differentials to exclude, especially if atypical or not responding: foreign body aspiration · pneumonia · anaphylaxis · pneumothorax · cardiac disease · vocal cord dysfunction · first-episode wheeze in an infant <1y (consider bronchiolitis rather than asthma)

13 · Weight-Based Medication Quick Reference

MedicationDoseNotes
Salbutamol (MDI + spacer)4–8 puffs, repeat q20min × 3100 mcg/puff; shake and use with spacer ± mask <4y
Salbutamol (nebulized)2.5 mg if <20 kg · 5 mg if ≥20 kgContinuous nebulization for severe/impending failure
Ipratropium (MDI + spacer)4–8 puffs, first 3 doses onlyCombine with salbutamol in moderate–severe disease
Ipratropium (nebulized)250 mcg if <20 kg · 500 mcg if ≥20 kgFirst 3 doses only — no added benefit beyond this
Dexamethasone0.3–0.6 mg/kg PO/IV/IM (max 16 mg)Single dose or short course
Prednisolone/prednisone1–2 mg/kg PO (max 40–60 mg)Once daily, 3–5 days
Magnesium sulfate40–50 mg/kg IV over 20 min (max 2 g)Severe asthma; may repeat once
Epinephrine (IM, severe/impending failure)0.01 mg/kg of 1:1000 (max 0.5 mg)Consider in impending respiratory failure
IV salbutamol infusionLoad 15 mcg/kg over 10 min, then 1–5 mcg/kg/minContinuous cardiac monitoring required

14 · Safety Warnings

  • ⚠️ Silent chest: minimal/absent wheeze does not mean mild disease — it can mean critical airflow obstruction; treat the whole clinical picture, not the wheeze alone
  • ⚠️ Do not intubate routinely in severe asthma — reserve for respiratory arrest or exhaustion unresponsive to maximal medical therapy; positive-pressure ventilation carries a high risk of barotrauma and cardiovascular collapse in severe bronchospasm
  • ⚠️ Mental status and trajectory override the numerical PRAM score — escalate on clinical deterioration even if the score has not yet risen
  • ⚠️ Involve PICU/critical care early for any severe or impending-failure presentation — do not wait for deterioration to be complete before calling for senior/airway support

15 · Pocket Card — ED Paediatric Asthma Algorithm

Wheezing child 1–18y
↓
Rapid visual triage — critical signs?
↓
Score PRAM
↓
Mild (0–4): salbutamol ± oral steroid
↓
Moderate (5–8): salbutamol + ipratropium ×3 + steroid
↓
Severe (9–12): continuous nebs + O₂ + IV steroid + IV magnesium + PICU
↓
Reassess after every phase
↓
Trend, not single score, drives disposition
← Back to all protocols